Figure 4. MOX treatment reduced SCI-induced up-regulation of IL-17, IFN-γ, MCP-1 and IL-1β expression. (A) Level of IL-17 in the SHAM group, SHAM+MOX group, SCI group and SCI+MOX group; (B) Level of IFN-γ in the SHAM group, SHAM+MOX group, SCI group and SCI+MOX group; (C) Level of MCP-1 in the SHAM group, SHAM+MOX group, SCI group and SCI+MOX group. (D) Level of IL-1β in the SHAM group, SHAM+MOX group, SCI group and SCI+MOX group.